Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2005
09/15/2005WO2003060473A3 Mucin immobilized chromatography
09/15/2005WO2003020881A3 DOMINANT NEGATIVE VARIANTS OF METHIONINE AMINOPEPTIDASE 2 (MetAP2) AND CLINICAL USES THEREOF
09/15/2005WO2003000844A3 Protein modification and maintenance molecules
09/15/2005WO2002085519A3 High capacity methods for separation, purification, concentration, immobilization and synthesis of compounds and applications based thereupon
09/15/2005WO2002048388A3 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
09/15/2005US20050204416 Plant cells having receptor polypeptides
09/15/2005US20050204412 Artery- and vein-specific proteins and uses therefor
09/15/2005US20050204410 SIRT6 transgenic non-human animals and assay methods
09/15/2005US20050204407 Methods for identifying and developing compounds that interact with voltage-gated potassium channels of the kv4 family
09/15/2005US20050203711 Method and apparatus for transmission line and waveguide testing
09/15/2005US20050203710 Parallel reaction executing apparatus, parallel reaction execution planning design apparatus, and parallel reaction executing method
09/15/2005US20050203709 Methods of analyzing multi-channel profiles
09/15/2005US20050203708 Method and system for microarray gradient detection and characterization
09/15/2005US20050203433 Methods of organ vitality assessment
09/15/2005US20050203432 Amount of deadspace which is provided in the apparatus can be adjusted to increase or decrease the volume of exhalate to be re-breathed by the patient, thereby decreasing ventilation without changing airway pressure; including a single two-way valve; simple to use, inexpensive and disposable
09/15/2005US20050203365 Method and apparatus for detecting endometriosis
09/15/2005US20050203356 Joint-diagnostic in vivo & in vitro apparatus
09/15/2005US20050203355 Method of assessing skin and overall health of an individual
09/15/2005US20050203345 Articulating paddle elevator and arthroscopic method for using same
09/15/2005US20050203177 Methods for selectively inhibiting janus tyrosine kinase 3 (JAK3)
09/15/2005US20050203098 Use of tyrosine kinase inhibitors for treating substance use disorders
09/15/2005US20050203065 Use of A2b adenosine receptor antagonists such as 3-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo[2.2.2]oct-1-yl]-propionic acid (BG 9928)
09/15/2005US20050203043 Identification of toxic nucleotide sequences
09/15/2005US20050203011 Increasing activity of glial cell line-derived neurotrophic factor (GDNF) or brain-derived neurotrophic factor (BDNF); alcohol abuse
09/15/2005US20050202733 Test object receptacle, test apparatus, and test method
09/15/2005US20050202582 Sensor arrangement with improved spatial and temporal resolution
09/15/2005US20050202573 Plurality of magnets that are arranged in such a way so as south and north poles of adjacent magnets are reversed alternate for use as components of immunoassay
09/15/2005US20050202572 Analytical apparatus comprising superconducting quantum interference device (SQUID) magnetic sensor for use in identifying preferentiial particles in blood
09/15/2005US20050202569 Integrated microchemical device
09/15/2005US20050202568 Fluid sample analysis device with sealable sample storage reservoir
09/15/2005US20050202567 Microfluidic apparatus comprising semiconductor components for determining concentration of glucose in blood
09/15/2005US20050202566 Multicompartment apparatus which utilizes scattered light to determine thrombin activity in blood
09/15/2005US20050202565 Reporter molecules based on squaric, croconic, and/or rhodizonic acid; photoluminescence
09/15/2005US20050202562 Volumetric Karl-Fischer titration with stabilized solvent
09/15/2005US20050202559 Cancer treatment by metabolic modulations
09/15/2005US20050202556 Process and spotting solution for preparing microarrays
09/15/2005US20050202555 Cell detection chip and fabricating method thereof and cell detecting method
09/15/2005US20050202550 Crystal structure of 3', 5'-cyclic nucleotide phosphodiesterase (PDE10A) and uses thereof
09/15/2005US20050202549 Phosphodiesterase crystal for identifying modulators for use in treatment and prevention of sexual, pain and psychological disorders; drug screening and design
09/15/2005US20050202529 Humanised antibodies
09/15/2005US20050202524 Tissue staining protocol and composition
09/15/2005US20050202523 fast detection and enumeration of low concentration of viable microorganisms using organic or inorganic substances that are entrapped in porous sol-gel glass
09/15/2005US20050202522 Using feast/famine regulatory proteins (FFRPs) as tool in screening for micobiocide and/or bactericides
09/15/2005US20050202521 Using glutathione, lipid peroxide and pyroglutamic acid blood plasma concentrations as diagnostic tool for measuring a systems utilization efficiency of anti-oxidant
09/15/2005US20050202517 Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP
09/15/2005US20050202515 Using vitamin d3 receptor (VDR) and modulator of non-genomic activity of nuclear receptors (MNAR) as tools in identifying compounds for prevention and treatment of cell proliferative and bone disorders
09/15/2005US20050202514 Using ligand immobilized solid support to screen and propagate cultures of preferential cells; tissue engineering
09/15/2005US20050202513 Method of judging cardiotoxicity of anthracycline-type anticancer chemical therapeutic by detecting human h-fabp and reagent therefor
09/15/2005US20050202512 Immunoglobulins; libraries; antibodies; complementary determining regions; immunoassay
09/15/2005US20050202511 AMP-activated protein kinase (AMPK) inhibitor screening assay
09/15/2005US20050202510 Method for identifying a site of protein-protein interaction for the rational design of short peptides that interfere with that interaction
09/15/2005US20050202509 Reagent for measuring clotting time and method for measuring clotting time
09/15/2005US20050202508 Biomarker for Parkinson's disease
09/15/2005US20050202506 Immunoglobulin for use in prevention and treatment of bone, glandular and kidney disorders; immunotherapy
09/15/2005US20050202505 Using oxidoreductase to determine inhibitory effects of 2-acetylbenzofuran; diagnosis and treatment of psychological disorders
09/15/2005US20050202503 Displacement assay for detection of small molecules
09/15/2005US20050202501 Using sequencing by hybridization as tool in detecting variance in genic sequences; identifying restriction fragment length polymorphism and/or single nucleotide polymorphisms
09/15/2005US20050202500 Using solid support comprising a multiplicity of immobilized probes as tool to determine transcript abundance in gene expression analysis; diagnosing cell proliferative disorders
09/15/2005US20050202499 Reagents and methods useful for detecting diseases of the breast
09/15/2005US20050202497 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/15/2005US20050202496 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/15/2005US20050202493 Method and apparatus for arranging liquid reaction components on substrate surface for detecting target substance by reaction among plural reaction components on substrate and article utilized in the method
09/15/2005US20050202487 Methods for isolation of bacteria from biological samples
09/15/2005US20050202485 Hepatic specific tumor polypeptides; diagnosing cell proliferative disorders of liver
09/15/2005US20050202481 Novel polypeptide ESDN, polynuleotides encoding the polypeptide, and utility of the polypeptide
09/15/2005US20050202476 Detection of microorganisms
09/15/2005US20050202475 Using chimeric membrane protein as diagnostic/prognostic indicator of cell proliferative disorders
09/15/2005US20050202474 Phosphodiesterases
09/15/2005US20050202472 Using long transient receptor potential channels (LTRPC2) as tools in identifying modulators for intracellular calcium concentration
09/15/2005US20050202469 Multiplexed analysis of clinical specimens apparatus and methods
09/15/2005US20050202467 Nucleotide sequences coding serotonin receptor (5-HT1A receptor) for use in identifying modulators for prevntion and treatment of neuropsychiatric disorders
09/15/2005US20050202466 Method for sequencing nucleic acid molecules
09/15/2005US20050202465 Using hyperdiploid state of thymidylate synthase gene as tool in diagnosis/prognosis of cell proliferative disorders
09/15/2005US20050202464 Radiative decay engineering
09/15/2005US20050202463 Modulators of dimethylarginine dimethylaminohydrolase and methods of use thereof
09/15/2005US20050202457 Preparing microarray comprising cell surface ligands for use as to in separation and classification of cell types
09/15/2005US20050202456 Processes for detecting or quantifying analytes of interest
09/15/2005US20050202455 Process for producing two or more copies of nucleic acids in a library, and process for detecting or quantifiying more than one nucleic acid in a library
09/15/2005US20050202454 "STRAP" and "STEAP"(six transmembrane (epithelial) antigen of the prostate)
09/15/2005US20050202451 Methods and apparatuses for diagnosing AML and MDS
09/15/2005US20050202447 Array print buffers
09/15/2005US20050202444 Sequential identification of linked molecules in a polymer, such as nucleotide bases of a nucleic acid, by passing the polymer through a nanometer-scale channel formed between a pair of nanoelectrodes
09/15/2005US20050202442 Novel therapeutic targets in cancer
09/15/2005US20050202440 Drug screening; nuclear receptor modulators; cocrystals
09/15/2005US20050202438 Using site directed mutagenesis to generate polypeptide of preferential function; two dimensional sequence analysis
09/15/2005US20050202431 Coumpound for use in diagnosis and treatment of cell proliferative disorders; gene therapy; antitumor agents
09/15/2005US20050202426 Whole cell engineering using real-time metabolic flux analysis
09/15/2005US20050202413 nucleic acid encoding an immunoreactive peptide not recognized by antibodies which are directed against other herpes-viruses for accurate diagnosis; test kits
09/15/2005US20050202411 Preparing biopsy of tumorous tissue and monitoring chemosensitivity to anticarcinogenic agents; antitumor agents
09/15/2005US20050202410 Precise efficacy assay methods for active agents inlcluding chemotherapeutic agents
09/15/2005US20050202409 Using amino acid sequence of polypeptide to determine heat resistant characteristics; protein folding
09/15/2005US20050202408 Chemical screening using a proline-rich nuclear receptor co-regulatory protein/nuclear receptor co-expression system
09/15/2005US20050202406 Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
09/15/2005US20050202404 Using nuclear images and plasma contraction as tool in characterizing cell populations
09/15/2005US20050202403 Yeast cells expressing modified G proteins and methods of use therefor
09/15/2005US20050202402 Tandem signaling assay
09/15/2005US20050202400 Method of classifying counting leucocytes
09/15/2005US20050202399 Method of assay by oxidation-reduction reaction with formazan
09/15/2005US20050202398 Use of biological photoreceptors as directly light-activated ion channels
09/15/2005US20050202396 Microarray with increased flexibility for use in gene expression analysis